GS-2829

N/A

Report date: 2025/07/17 16:56:22

Base Information

Drug NameGS-2829
Drug Alias NameHB-400 programalternating PICV-LCMV vector based vaccine GS-2829 (Hookipa Pharma/Gilead Sciences)alternating two-vector arenavirus-based vaccine (GS-2829 vectors) (Hookipa Pharma/Gilead Sciences)Hepatitis B virus Vaccine GS-2829（Gilead）GS-2829 +[6] 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwanNew Zealand
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGilead Sciences IncHookipa Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesGilead Sciences Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A